Greenhouse Funds’s Evolent Health EVH Stock Holding History

Greenhouse Funds’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,406,546	Closed	-$38.3M	–	38
2023 Q3	$38.3M	Buy	1,406,546 +7,286	+0.5%	+$203K	2.83%	19
2023 Q2	$42.4M	Buy	1,399,260 +60,081	+4%	+$1.94M	3.31%	15
2023 Q1	$43.5M	Sell	1,339,179 -518,629	-28%	-$16.4M	3.64%	11
2022 Q4	$52.2M	Buy	1,857,808 +347,594	+23%	+$9.96M	4.76%	4
2022 Q3	$54.3M	Buy	1,510,214 +29,544	+2%	+$1.04M	6.19%	2
2022 Q2	$45.5M	Buy	1,480,670 +154,713	+12%	+$4.51M	5.01%	7
2022 Q1	$42.8M	Buy	1,325,957 +128,859	+11%	+$3.37M	4.32%	8
2021 Q4	$33.1M	Buy	1,197,098 +103,137	+9%	+$2.96M	3.1%	15
2021 Q3	$33.9M	Buy	1,093,961 +78,567	+8%	+$1.89M	3.42%	14
2021 Q2	$21.4M	Buy	+1,015,394	New	+$20.3M	1.88%	22

Other funds holding EVH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Greenhouse Funds's EVH Position: Q4 2023 in Review

Greenhouse Funds sold out of Evolent Health (EVH) in Q4 2023, closing a stake of 1,406,546 shares — an estimated $38.3M sold.

Greenhouse Funds first reported a position in EVH in Q2 2021 and held it in 10 quarters. The position peaked at $54.3M in Q3 2022. 234 funds tracked by Wall St. Rank hold EVH as of Q4 2023.

Greenhouse Funds reported no remaining Evolent Health position as of Q4 2023 after selling out during the quarter.
Greenhouse Funds sold 1,406,546 Evolent Health shares in Q4 2023, an estimated $38.3M.
Greenhouse Funds first reported a position in Evolent Health in Q2 2021 and held it in 10 quarters.
Greenhouse Funds's Evolent Health position peaked at $54.3M in Q3 2022.
234 funds tracked by Wall St. Rank held Evolent Health as of Q4 2023.

Based on Greenhouse Funds's 13F filing for Q4 2023, filed 14 Feb 2024.